127 related articles for article (PubMed ID: 15225831)
21. Effect of calcitriol on prostate-specific antigen in vitro and in humans.
Beer TM; Garzotto M; Park B; Mori M; Myrthue A; Janeba N; Sauer D; Eilers K
Clin Cancer Res; 2006 May; 12(9):2812-6. PubMed ID: 16675575
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
23. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
24. [Transcriptional regulation of placental transforming growth factor-beta by calcitriol in prostate cancer cells is androgen-independent].
Nazarova NIu; Chikhirzhina GI; Tuohimaaa P
Mol Biol (Mosk); 2006; 40(1):84-9. PubMed ID: 16523695
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
Kendrick JE; Straughn JM; Oliver PG; Wang W; Nan L; Grizzle WE; Stockard CR; Alvarez RD; Buchsbaum DJ
Gynecol Oncol; 2008 Mar; 108(3):591-7. PubMed ID: 18177927
[TBL] [Abstract][Full Text] [Related]
26. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
27. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth.
Gavrilov V; Steiner M; Shany S
Anticancer Res; 2005; 25(5):3425-9. PubMed ID: 16101159
[TBL] [Abstract][Full Text] [Related]
28. Development of weekly high-dose calcitriol based therapy for prostate cancer.
Beer TM
Urol Oncol; 2003; 21(5):399-405. PubMed ID: 14670552
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D in combination cancer treatment.
Ma Y; Trump DL; Johnson CS
J Cancer; 2010 Jul; 1():101-7. PubMed ID: 20842231
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.
Krishnan AV; Feldman D
Annu Rev Pharmacol Toxicol; 2011; 51():311-36. PubMed ID: 20936945
[TBL] [Abstract][Full Text] [Related]
31. Calcitriol Combined With Platinum-based Chemotherapy Suppresses Growth and Expression of Vascular Endothelial Growth Factor of SKOV-3 Ovarian Cancer Cells.
Kim JH; Park WH; Suh DH; Kim K; No JH; Kim YB
Anticancer Res; 2021 Jun; 41(6):2945-2952. PubMed ID: 34083285
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone.
Yu WD; McElwain MC; Modzelewski RA; Russell DM; Smith DC; Trump DL; Johnson CS
J Natl Cancer Inst; 1998 Jan; 90(2):134-41. PubMed ID: 9450573
[TBL] [Abstract][Full Text] [Related]
33. Calcitriol in cancer treatment: from the lab to the clinic.
Beer TM; Myrthue A
Mol Cancer Ther; 2004 Mar; 3(3):373-81. PubMed ID: 15026558
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.
Trump DL; Deeb KK; Johnson CS
Cancer J; 2010; 16(1):1-9. PubMed ID: 20164683
[TBL] [Abstract][Full Text] [Related]
35. Recent Progress in the Treatment of Advanced Prostate Cancer With Intermittent Dose-Intense Calcitriol (DN-101).
Brawer MK
Rev Urol; 2007; 9(1):1-8. PubMed ID: 17396166
[TBL] [Abstract][Full Text] [Related]
36. Rationale for the development and current status of calcitriol in androgen-independent prostate cancer.
Beer TM; Myrthue A; Eilers KM
World J Urol; 2005 Feb; 23(1):28-32. PubMed ID: 15668801
[TBL] [Abstract][Full Text] [Related]
37. A New Formulation of Calcitriol (DN-101) for High-Dose Pulse Administration in Prostate Cancer Therapy.
Henner WD; Beer TM
Rev Urol; 2003; 5 Suppl 3(Suppl 3):S38-44. PubMed ID: 16985949
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic Effects of Calcitriol in Cancer Biology.
Díaz L; Díaz-Muñoz M; García-Gaytán AC; Méndez I
Nutrients; 2015 Jun; 7(6):5020-50. PubMed ID: 26102214
[TBL] [Abstract][Full Text] [Related]
39. The mechanism of calcitriol in cancer prevention and treatment.
Ma J; Ma Z; Li W; Ma Q; Guo J; Hu A; Li R; Wang F; Han S
Curr Med Chem; 2013; 20(33):4121-30. PubMed ID: 23895685
[TBL] [Abstract][Full Text] [Related]
40. S179D Prolactin Sensitizes Human PC3 Prostate Cancer Xenografts to Anti-tumor Effects of Well-Tolerated Doses of Calcitriol.
Holland CT; Hsu J; Walker AM
J Cancer Sci Clin Ther; 2020; 4(4):442-456. PubMed ID: 33179012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
